Axe Compute Inc (AGPU)
Axe Compute Inc. is a Nasdaq-listed common stock issuer based in Pittsburgh, Pennsylvania. The company, incorporated in 2002, operates as a healthcare technology and equipment business with two reported segments: Pittsburgh and Eagan. In its Pittsburgh segment, Axe Compute applies artificial intelligence to support cancer therapy discovery and development, using a proprietary biobank of more than 150,000 tumor samples and developing 3D culture models for drug research. Its Eagan segment manufactures the FDA-cleared STREAMWAY System and related products for automated medical fluid waste management and patient-to-drain disposal. The company was formerly known as Predictive Oncology Inc. and adopted the Axe Compute Inc. name in December 2025. It also has a strategic collaboration with Every Cure focused on identifying and prioritizing drugs for repurposing.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AGPU
|
$6.96
|
-29.2% Downside
|
Overvalued
|
—
|
—
|
—
|
Weak
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-0.4x
|
2.3x
|
1,802.2x
|
90.624 M
|
85.132 M
|
1.6%
|
81.6%
|
-3.3
|
—
|
5.4%
|
